Paid Clinical Trials in Saint Louis Park, MN
As of July 2026, 125 paid clinical trials are recruiting in Saint Louis Park, Minnesota. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Saint Louis Park offers studies at sites including Park Nicollet Clinic - Saint Louis Park for conditions such as Acute Myeloid Leukemia, Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Saint Louis Park
Trials by drug in Saint Louis Park
Filter results
Newly added in Saint Louis Park
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
125 clinical trials
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
XTX301 in Patients With Advanced Solid Tumors
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Axelopran for Advanced Cancer in Patients Receiving Opioids
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Family Communications After Genetic Testing
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Top Research Study Locations in Saint Louis Park
Researchers run research studies in Saint Louis Park, MN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Park Nicollet Clinic - Saint Louis Park | Acute Myeloid Leukemia, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 87 |
| Retina Consultants of Minnesota | Macular Edema Secondary to Inflammation, Geographic Atrophy, Macular Degeneration | 4 |
| HealthPartners Frauenshuh Cancer Center | Advanced or Metastatic Solid Tumors, Brain Neoplasms, Breast Cancer, Metastatic | 4 |
| Metro-Minnesota Community Clinical Oncology | Breast Neoplasms, Neoplasm Metastasis, Triple-Negative Breast Cancer | 3 |
| Metro Minnesota Community Oncology Research Consortium (MMCORC) | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | 2 |
| Park Nicollet Frauenshuh Cancer Center | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Colorectal Neoplasms | 2 |
| HealthPartners Cancer Research Center | Colorectal Cancer Metastatic, Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable | 2 |
| HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center | Prostate Cancer, Prostatic Neoplasms, Metastatic Castration-resistant Prostate Cancer (mCRPC) | 2 |
| Metro Minnesota Community Oncology Research Consortium (MMCORC) | Hepatocellular Carcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
| Health Partners - Frauenshuh Cancer Center | Ductal Carcinoma in Situ | 1 |
| Health Partners Frauenshuh Cancer Center | Advanced Solid Tumor, Bladder Cancer, Breast Cancer | 1 |
| HealthPartners Frauenshuh Cancer Center CRC West | Prostatic Neoplasms, Castration-Resistant | 1 |
| HealthPartners Frauenshuh Cancer Research Center | Breast Cancer, Lung Cancer, Pancreas Cancer | 1 |
| HealthPartners Institute Cancer Research Center | Cancer, Cannabis Use | 1 |
| IDC at Park Nicollet | Gestational Diabetes Mellitus in Pregnancy | 1 |
| Methodist Hospital | Cardiovascular Disease | 1 |
| Methodist Hospital Inpatient Pharmacy | Advanced or Metastatic Solid Tumors, Brain Neoplasms, Differentiated Thyroid Cancer | 1 |
| Metro MN | Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell Lung Cancer, Stage III Lung Cancer | 1 |
| Metro Minnesota Community Oncology | Triple Negative Breast Cancer | 1 |
| Metro Minnesota Community Oncology Consortium (MMCORC) | Breast Cancer | 1 |
| Metro Minnesota Community Oncology Research Consortium | Colorectal Neoplasms | 1 |
| Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center | Angiosarcoma, Breast Cancer, Breast Neoplasms | 1 |
| Metro-Minnesota Community Clinical Oncology | Prostate Cancer Metastatic | 1 |
Active & Upcoming Studies in Saint Louis Park (2026)
Recruiting trials in Saint Louis Park grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (102 active studies)
- A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) · Phase 3 · EMD Serono Research & Development Institute, Inc.
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Eye & vision (5 active studies)
Diabetes & metabolic (2 active studies)
Mental health & behavior (1 active study)
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Common conditions studied in Saint Louis Park
- Acute Myeloid Leukemia (6 active studies)
- Breast Cancer (6 active studies)
- Stage IIIB Lung Cancer AJCC v8 (5 active studies)
- Stage IV Lung Cancer AJCC v8 (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Chronic Lymphocytic Leukemia (4 active studies)
Leading research sponsors in Saint Louis Park
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Saint Louis Park?
There are approximately 125 recruiting clinical trials in Saint Louis Park, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Saint Louis Park pay participants?
Most recruiting trials in Saint Louis Park compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Saint Louis Park?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Saint Louis Park?
The most common conditions under active study in Saint Louis Park include Acute Myeloid Leukemia (6), Breast Cancer (6), Stage IIIB Lung Cancer AJCC v8 (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Saint Louis Park?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Saint Louis Park on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Saint Louis Park?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Saint Louis Park?
Recruiting research sites in Saint Louis Park include Park Nicollet Clinic - Saint Louis Park, Retina Consultants of Minnesota, HealthPartners Frauenshuh Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Saint Louis Park right now?
The largest active categories in Saint Louis Park are Cancer & tumors (102), Eye & vision (5), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.